Extension of Mologic tie up24 Apr 2020 10:39
I thought the announcement might have dropped today but I think it will now almost certainly be on Monday. The announcement I think is pending is that ODX will partner up with Mologic to produce their POC test which, like their elisa lab test, has reached design freeze and is 'ready' to be manufactured. The only question mark is how will this impact or tie up with the UK-RTC? Well, perhaps Mologic will either join the consortium or the agreement will be separate, and in addition to, the MOU that ODX have with the UK-RTC. I cannot see any restriction on ODX making this additional arrangement because there is not yet any binding contract/legal agreement with the UK-RTC which prevents them from doing so.
Why do I think this agreement is going to be announced? There are clues out there. The first is in this link:
https://mologic.co.uk/covid-19-update-17-april-2020/
In the above announcement Mologic confirm they have completed design freeze for their POC test (yes Piper they have one!)
Who would they choose to partner up with to manufacture their test? A company that they have a relationship with already perhaps? A company that has proven POC lateral flow test expertise certainly. They are applying for the CE mark.
The next clue is Colin King discloses when discussing the lab test that it had only come about whilst discussing 'other matters' with the Mologic CEO. For me, those 'other matters' surely could only have been regarding the POC test. But at that stage they weren't quite ready as ODX are having to work out how they will scale up their manufacturing capability for the POC test to accommodate Mologic. Colin King has admitted as such.
Finally, in the Mologic link I posted above they say and I quote:
"Mologic will be announcing several critical milestones in the coming week, including open access publication of the full data and additional results."
And there you have it folks. For me the jigsaw puzzle is solved. Next week is going to be very very interesting indeed.